This Amendment proposed changes in pharmacy coverage required by Section 175 of the Medicare Improement for Patients and Oroviders Act of 2008 which amended section 1860D-2 (e) 2 (A) of the Act in include barbiturates" used in the treatment of epilepsy, cancer, or chronic mental health disorder" and benzodiazepines in Part D drug coverage.
State
Topics
Approval Date
Effective Date
File 1 - Approval Document Media